Buscar

Mostrando ítems 1-10 de 197

Apremilast, an oral phosphodiesterase 4 inhibitor, is associated with long-term (52-week) improvement in measures of disease activity in patients with psoriatic arthritis: Results from 3 phase 3, randomized, controlled trials

2014- Gómez-Reino Carnota, Juan Jesús

Positive effect of stringent criteria for PPD skin test on CZP patients

2014- Gómez-Reino Carnota, Juan Jesús

Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials

2015- Gómez-Reino Carnota, Juan Jesús

Body mass does not affect clinical outcomes of therapy with abatacept in rheumatoid arthritis (RA) patients. A pan-european analysis of RA registries

2014- Iannone, F.; Finckh, A.; Neto, D.; Gómez-Reino Carnota, Juan Jesús; Lie, E.; [et al.]

Antibodies against Carbamylated Proteins (ANTI-CARP), a new type of autoantibody, in spanish patients with rheumatoid arthritis

2014- Gómez-Reino Carnota, Juan Jesús; González Martínez-Pedrayo, Antonio; Montes Martínez, Ariana María; Pérez Pampín, Eva; Bóveda Fontán, María Dolores

Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexa

2015- Gómez-Reino Carnota, Juan Jesús

Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration.

2012- Gómez-Reino Carnota, Juan Jesús

Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial

2012- Gómez-Reino Carnota, Juan Jesús

Biologic monotherapy as initial treatment in patients with early rheumatoid arthritis

2012- Gómez-Reino Carnota, Juan Jesús

Adipokines induce inflammatory mediators in CD4DT cells and modulate the cross talk between CD4D T lymphocytes and chondrocytes from OA patients

2014- Gómez-Reino Carnota, Juan Jesús; Scotece, Morena; Gualillo ., Oreste; Pino Mínguez, Jesús; Conde Aranda, Javier; [et al.]

1
2
3
4
. . .
20